Second, although HMGB1 has the potential to promote Th17 cell differentiation and induce IL‐17 expression in PBMCs of psoriasis patients by IL‐23 and TLR4 signaling pathways, more detailed mechanisms need to be explored and explained. This evidence concerns the gene IL17A and psoriasis.